Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury - sprookjes - yvandenbroek - TriplyDB

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

http://www.wikidata.org/entity/Q36431793

about

Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury Is lipid signaling through cannabinoid 2 receptors part of a protective system?Beta-caryophyllene is a dietary cannabinoid CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes Modulation of cellular redox homeostasis by the endocannabinoid system Therapeutic potential of monoacylglycerol lipase inhibitors The role of endocannabinoids system in fatty liver disease and therapeutic potentials Developmental origins of NAFLD: a womb with a clue.Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis.Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.Cannabinoids as novel anti-inflammatory drugs.The endocannabinoid system: 'NO' longer anonymous in the control of nitrergic signalling?Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.CB2 receptor activation ameliorates the proinflammatory activity in acute lung injury induced by paraquat.Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity.Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke.Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis The cannabinoid WIN55,212-2 protects against oxidized LDL-induced inflammatory response in murine macrophages.Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model.Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells.Peroxisomal and microsomal lipid pathways associated with resistance to hepatic steatosis and reduced pro-inflammatory state.CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?Regulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease.CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.Endocannabinoids in liver disease.Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings Sulforaphane, a natural constituent of broccoli, prevents cell death and inflammation in nephropathy Protective role of cannabinoid receptor 2 activation in galactosamine/lipopolysaccharide-induced acute liver failure through regulation of macrophage polarization and microRNAs.Endocannabinoid signaling at the periphery: 50 years after THC.β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury

P2860

Q24595633-81B54223-9775-4DDC-837C-9CAFD78DAAFB Q24633122-A462D659-3CD5-4FB3-AD69-E61B97048839 Q24645478-79786729-56D0-4264-9D0C-70B3A05DBF21 Q24649936-56259B28-B3C7-450A-8EF6-DBB9D07B429D Q26744211-0D599850-67B7-4B22-9849-493720E098C7 Q26991513-E0DC7BBD-4AC1-44F0-986F-3EE79C5F2BFD Q27009466-29F4D2EE-C71D-46D1-AA1B-7AF4151EDD26 Q30241940-3DC279F0-968E-4EA6-9519-9EF8ED94C7AF Q33464957-2BAA49C5-48FE-4EFB-BF4B-889504D7E938 Q33488512-DD6A22DD-D8F3-4EB8-89B9-0EDC11DCAE1E Q33602403-B4A9BE38-9223-4355-9405-A882F6E12417 Q33688381-A03D539B-8C92-4BF0-BA56-3C2333CCCDB0 Q33712156-700B181C-E4B1-4492-88E4-6F841CE9549E Q33714587-8B44639D-41FF-4C21-BE0C-682154305068 Q33745557-8B31A028-6FF7-418F-A867-46D30628F243 Q33792047-22C0B3DD-CC92-4978-BE3E-3CB66AB32AC4 Q33793559-3DCE5029-CA00-473A-9EF1-2200A86A375F Q33847549-5AB3918C-B274-42B9-826F-FE0099655864 Q33920996-9B271441-4C7E-488F-972E-AD32BAAE7E9E Q33947213-49BC03EC-91F5-41E7-AF3D-50FDF29C576A Q33993080-D5BA25FD-D906-425D-9586-73218D55F235 Q34069579-D667385B-2626-4E20-B450-0A54FC9DDBB3 Q34098258-AEA94DCB-E56D-4546-8231-E33BB4BB3676 Q34098271-10566CF4-6E2B-45F0-A231-050CADD8D24A Q34155467-D25EC257-4ED3-4117-B0C4-48E5B7BAEEA5 Q34186015-7745930F-4C3B-4F29-915C-6A611762868F Q34471868-859DD81C-609D-4F5B-9898-F5F9E10C101E Q34655802-029A1C88-D2C4-4877-9C40-502BBA54819A Q34657057-9365CBB2-4D1F-4219-9ECD-88A5F0BA530F Q34664067-0B4E1FF7-78C7-46EA-961E-92C9BFF4FE8A Q34733645-3AD764C3-3CBB-4A70-923C-8FED5D6FA251 Q34776919-ED969B51-7C9E-49B2-A3EC-3A8DBB4EAEC3 Q34851941-C24C94F4-D31B-423F-A2C1-20695AC0571D Q35193292-B5A5704A-7BAB-48E5-9DCA-290A0D45EED1 Q35231426-A083BA3A-0B51-433F-B7EF-DFF5418CD490 Q35531807-8D01A21B-3F6D-4DDC-A116-652615CB48CC Q35572176-BDC0F2CF-AC24-40F7-BDBB-29DD6A5E4547 Q35854652-783C0389-8938-4975-BF6E-F2C416A8F855 Q36176486-2947D60C-DE28-4D5D-A12C-CAE71B78B1A6 Q36176499-46188F1B-F2FC-4149-AACD-B195F75654B2

P2860

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

http://www.wikidata.org/entity/Q36431793

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

@ast

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

@en

type

label

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

@ast

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

@en

prefLabel

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

@ast

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

@en

P1433

Q36431793-740A6216-8F0A-41FC-BBCE-084607423F6E

P1476

Q36431793-8F629D3E-B45A-41FC-85C3-55F6E812C478

P2093

Q36431793-275F2FDF-AFAB-4355-A6C1-EE89147D4796

Q36431793-2EEE77BE-4B1F-40F9-B1C1-ADB69D078D50

Q36431793-3FEAE199-A802-4F1C-8DA7-ECB34ACE0FAF

Q36431793-4D54BB65-A0CC-4474-88B1-F94A2FC75C29

Q36431793-50992AC2-06B7-494B-AF43-880B5D977578

Q36431793-69B62C95-25AC-409E-9856-4319B2D9D3FC

Q36431793-A12C7909-7046-47CD-9E0F-85B9C67F9650

Q36431793-CCADD0C1-988B-4F7B-A0D0-D9972335E79A

Q36431793-D04A6ACC-F747-44E0-ACCA-3308D2628D62

P2860

Q36431793-07CD6C00-BBC5-47A0-BB7D-2EFC6BCEBB34

Q36431793-09D68E06-65B8-4CE8-ABC3-5997A5C234AE

Q36431793-0AA88A54-1FC0-4CA3-BF38-305207A2C4CC

Q36431793-0F4AC36F-4D7A-4397-B20C-BE54312878BA

Q36431793-1081676E-C4DF-4776-85EC-6CA50723267F

Q36431793-179E3214-0041-4B79-8EE7-FC46BC87F8AA

Q36431793-23BF513F-4A98-4E15-B18D-786C8A3FC5FB

Q36431793-24E83074-DC56-405B-9586-29D2FFC38BA5

Q36431793-25D15CCE-A86E-42EC-8D90-716BD771BF57

Q36431793-2F161291-8115-4604-93C2-1E3B22962607

P304

Q36431793-70C9052A-F4E5-4C81-AA5D-44249F7D9EAD

P31

Q36431793-15ABE553-FB58-436C-95B8-821A24708A32

P356

Q36431793-F881369D-0D3D-4A59-B5FB-14613F413703

P407

Q36431793-1E1A11C7-3C2E-43A3-B8E6-B0623EAFCAC8

P433

Q36431793-D8A4153A-5F91-48E1-A58C-163297A0EF27

P478

Q36431793-329DB31E-EA05-4622-A976-AF1A90A8935F

P50

Q36431793-2B3717B7-796F-4967-BCD9-04CDC63A66D4

Q36431793-8BFF53D3-AEA1-4602-A273-081CDE9F995F

Q36431793-9AF3E789-7AFF-47EF-97FC-6A9FE461ABE8

Q36431793-B2BDC4B2-D927-4206-8177-C1946F115CC0

Q36431793-B518CB49-8A43-465C-B493-FE03BD5178BA

P577

Q36431793-909B325B-B758-4734-AEEA-DF1C036BB3DD

P5875

Q36431793-38C6D1B8-6A16-4D64-83E3-949AEBED8EBA

P698

Q36431793-EA7C4514-F35A-4BE6-8BD6-E0A8B0A13164

P921

Q36431793-44647b3a-3ed1-41d9-b73c-997fae6ea1cc

Q36431793-504DAB90-20B7-475D-85DA-3E2C612D07E8

Q36431793-85006F46-9613-44FD-BED9-E1D2582A1EAC

Q36431793-E29B80DC-826E-46E5-985F-34ED7E333C2B

P932

Q36431793-D808F465-A046-43F7-AD80-13064D03D31C

P356

P1433

P1476

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

@en

P2093

Anjum Jafri

http://www.w3.org/2001/XMLSchema#string

Bin Gao

http://www.w3.org/2001/XMLSchema#string

Feng Hong

http://www.w3.org/2001/XMLSchema#string

George Kunos

http://www.w3.org/2001/XMLSchema#string

György Haskó

http://www.w3.org/2001/XMLSchema#string

Judith Harvey-White

http://www.w3.org/2001/XMLSchema#string

Mohanraj Rajesh

http://www.w3.org/2001/XMLSchema#string

Osama El-Assal

http://www.w3.org/2001/XMLSchema#string

Sándor Bátkai

http://www.w3.org/2001/XMLSchema#string

P2860

The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

Peripheral cannabinoid receptor, CB2, regulates bone mass.

N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

Nitric oxide and peroxynitrite in health and disease

The endocannabinoid system as an emerging target of pharmacotherapy

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol

Activation of the peripheral endocannabinoid system in human obesity

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

P304

1788-1800

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.06-7451COM

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Partha Mukhopadhyay

Douglas Osei-Hyiaman

John W. Huffman

P577

2007-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6479888

http://www.w3.org/2001/XMLSchema#string

P698

17327359

http://www.w3.org/2001/XMLSchema#string

P921

reperfusion injury

cannabinoid receptor

P932

2228252

http://www.w3.org/2001/XMLSchema#string